These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy. Yoshida S, Sakurai Y, Takeda T, Fukuda K. J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975 [No Abstract] [Full Text] [Related]
11. Kawasaki disease in Calcutta. Paul DK, Gupta A, Lahiri M. Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312 [No Abstract] [Full Text] [Related]
13. The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease. Kaneka K, Savage CO, Pottinger BE, Shah V, Pearson JD, Dillon MJ. Pediatr Infect Dis J; 1994 Nov; 13(11):1022-3. PubMed ID: 7845731 [No Abstract] [Full Text] [Related]
14. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease. Shulman ST. Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455 [No Abstract] [Full Text] [Related]
16. Incomplete Kawasaki disease: a pediatric diagnostic conflict. Celik U, Alhan E, Arabaci F. Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242 [No Abstract] [Full Text] [Related]
17. Kawasaki disease refractory to standard treatments that responds to a combination of pulsed methylprednisolone and plasma exchange: Cytokine profiling and literature review. Matsui M, Okuma Y, Yamanaka J, Uryu H, Sato N, Shichino H, Matsushita T. Cytokine; 2015 Aug; 74(2):339-42. PubMed ID: 25801094 [Abstract] [Full Text] [Related]